Author

L. Lopez Quezada

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. L. Gard· 1 shared C. R. Fisher· 1 shared E. P. Gabriel· 1 shared F. Mba Medie· 1 shared J. T. Borenstein· 1 shared L. D. Rubio· 1 shared R. J. Luu· 1 shared T. J. Mulhern· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. L. Gard

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A human primary airway microphysiological system infected with SARS-CoV-2 distinguishes the treatment efficacy between nirmatrelvir and repurposed compounds fluvoxamine and amodiaquine

L. Lopez Quezada, F. Mba Medie, E. P. Gabriel, R. J. Luu, L. D. Rubio, T. J. Mulhern, J. T. Borenstein, C. R. Fisher, A. L. Gard

This study evaluates the antiviral efficacy of nirmatrelvir and repurposed drugs against SARS-CoV-2 using a human airway microphysiological system, showing discrepancies with prior in vitro results.

bioRxiv · Jun 27, 2023 · PreprintBioengineering